Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial

2020141 citationsJournal Articlehybrid Open Access

Authors

Nicole van der Wielen

Jennifer Straatman · University of Amsterdam

Freek Daams

Riccardo Rosati

Paolo Parise

Jürgen Weitz · University Hospital Carl Gustav Carus

Christoph Reißfelder · University Hospital Heidelberg

Ismael Díez del Val · Hospital de Basurto

Carlos Loureiro

Abstract

These findings provide evidence that MITG after neoadjuvant therapy is not inferior regarding oncological quality of resection in comparison to OTG in Western patients with resectable gastric cancer. In addition, no differences in postoperative complications and recovery were seen.

Topics & Keywords

Gastric Cancer Management and Outcomes Metastasis and carcinoma case studies Gastrointestinal Tumor Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Gastric Cancer

Volume 24, Issue 1, pp. 258-271

DOI: 10.1007/s10120-020-01109-w

Field-Weighted Citation Impact: 10.89